In-Vitro Study of Urokinase Thrombolysis Following Stereotactic Aspiration of Intracerebral Hematoma |
Son, Wonsoo
(Department of Neurosurgery, School of Medicine, Kyungpook National University)
Park, Jaechan (Department of Neurosurgery, School of Medicine, Kyungpook National University) Kang, Dong-Hun (Department of Neurosurgery, School of Medicine, Kyungpook National University) Han, Young-Min (Department of Neurosurgery, School of Medicine, Kyungpook National University) Choi, Yeon-Ju (Department of Neurosurgery, School of Medicine, Kyungpook National University) Ohk, Boram (Department of Clinical Trial Center, Kyungpook National University Hospital) |
1 | Teernstra OP, Evers SM, Lodder J, Leffers P, Franke CL, Blaauw G : Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34 : 968-974, 2003 DOI |
2 | Wang GQ, Li SQ, Huang YH, Zhang WW, Ruan WW, Qin JZ, et al. : Can minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study. Mil Med Res 1 : 10, 2014 DOI |
3 | Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C : Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 35 : 159-162, 1993 DOI |
4 | Aydin IH, Takci E, Kadioglu HH, Kayaoglu CR, Tuzun Y : The effect of urokinase on experimental intracerebral haematomas. Zentralbl Neurochir 55 : 29-34, 1994 |
5 | Chang YH, Hwang SK : Frameless stereotactic aspiration for spontaneous intracerebral hemorrhage and subsequent fibrinolysis using urokinase. J Cerebrovasc Endovasc Neurosurg 16 : 5-10, 2014 DOI |
6 | Chen X, Chen W, Ma A, Wu X, Zheng J, Yu X, et al. : Frameless stereotactic aspiration and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral haemorrhage. Br J Neurosurg 25 : 369-375, 2011 DOI |
7 | Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, et al. : Immunotherapy blocking the tissue plasminogen activatordependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome. Neuropharmacology 67 : 267-271, 2013 DOI |
8 | Gaberel T, Montagne A, Lesept F, Gauberti M, Lemarchand E, Orset C, et al. : Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis. Neuropharmacology 85 : 158-165, 2014 DOI |
9 | Keric N, Maier GS, Samadani U, Kallenberg K, Dechent P, Brueck W, et al. : Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration. Transl Stroke Res 3 : 88-93, 2012 DOI |
10 | Lian L, Xu F, Hu Q, Liang Q, Zhu W, Kang H, et al. : No exacerbation of perihematomal edema with intraclot urokinase in patients with spontaneous intracerebral hemorrhage. Acta Neurochir (Wien) 156 : 1735-1744, 2014 DOI |
11 | Lippitz BE, Mayfrank L, Spetzger U, Warnke JP, Bertalanffy H, Gilsbach JM : Lysis of basal ganglia haematoma with recombinant tissue plasminogen activator (rtPA) after stereotactic aspiration: initial results. Acta Neurochir (Wien) 127 : 157-160, 1994 DOI |
12 | Naval NS, Nyquist P, Carhuapoma JR : ICH aspiration and thrombolysis. J Neurol Sci 261 : 80-83, 2007 DOI |
13 | Meunier JM, Wenker E, Lindsell CJ, Shaw GJ : Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse". Acad Emerg Med 20 : 449-455, 2013 DOI |
14 | Montes JM, Wong JH, Fayad PB, Awad IA : Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke 31 : 834-840, 2000 DOI |
15 | Narayan RK, Narayan TM, Katz DA, Kornblith PL, Murano G : Lysis of intracranial hematomas with urokinase in a rabbit model. J Neurosurg 62 : 580-586, 1985 DOI |
16 | Niizuma H, Otsuki T, Johkura H, Nakazato N, Suzuki J : CT-guided stereotactic aspiration of intracerebral hematoma--result of a hematomalysis method using urokinase. Appl Neurophysiol 48 : 427-430, 1985 |
17 | Ouriel K, Welch EL, Shortell CK, Geary K, Fiore WM, Cimino C : Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. J Vasc Surg 22 : 593-597, 1995 DOI |
18 | Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF : Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb J 4 : 14, 2006 |
19 | Rohde V, Rohde I, Thiex R, Ince A, Jung A, Duckers G, et al. : Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97 : 954-962, 2002 DOI |
20 | Samadani U, Rohde V : A review of stereotaxy and lysis for intracranial hemorrhage. Neurosurg Rev 32 : 15-21; discussion 21-22, 2009 DOI |
21 | Tan Q, Chen Q, Niu Y, Feng Z, Li L, Tao Y, et al. : Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage. J Neurosurg 126 : 548-557, 2017 DOI |
![]() |